WuXi Biologics (Cayman) Inc 2269-HK:Hong Kong Stock Exchange

*Data is delayed | HKD
Last | 08/12/22 CTT
70.85quote price arrow down-1.10 (-1.53%)
Volume
11,791,463
52 week range
40.30 - 130.00
Loading...
  • Open72.00
  • Day High72.25
  • Day Low69.90
  • Prev Close71.95
  • 52 Week High130.00
  • 52 Week High Date08/10/21
  • 52 Week Low40.30
  • 52 Week Low Date03/15/22

Key Stats

  • Market Cap38,497.32M
  • Shares Out4,259M
  • 10 Day Average Volume16.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change-23.45

KEY STATS

  • Open72.00
  • Day High72.25
  • Day Low69.90
  • Prev Close71.95
  • 52 Week High130.00
  • 52 Week High Date08/10/21
  • 52 Week Low40.30
  • 52 Week Low Date03/15/22
  • Market Cap38,497.32M
  • Shares Out4,259M
  • 10 Day Average Volume16.37M
  • Dividend-
  • Dividend Yield-
  • Beta1.4
  • YTD % Change-23.45

RATIOS/PROFITABILITY

  • EPS (TTM)1.00
  • P/E (TTM)71.06
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On WuXi Biologics (Cayman) Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
WuXi Biologics Cayman Inc is an investment holding company principally engaged in provision of discovery, development and manufacturing services of biologics. Through fully-integrated biologics Contract Research, Development and Manufacturing Organization (CRDMO), the Company provides one-stop end-to-end biologics services. Biologics development process stages include pre-IND (drug discovery and pre-clinical development), early-phase (phases I & II) clinical development...
Ge Li Ph.D.
Non-Executive Chairman of the Board
Zhisheng Chen
Chief Executive Officer, Executive Director
Ming Tu
Chief Financial Officer
Jijie Gu Ph.D.
Executive Vice President, Chief Scientific Officer
Weichang Zhou
Executive Vice President, Chief Technology Officer, Executive Director
Angus Scott Turner
Vice President - Global business development and Alliance Management
Address
No. 108, Meiliang Road, Mashan
Wuxi, JNG
China